European Vaccine Initiative (EVI), Heidelberg, Germany Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2014
NCT01949909
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

European Vaccine Initiative